Our visionary team brings a wide range of different expertise to the table, all to meet a single goal — helping our clients navigate the complexities of today’s life sciences industry through vision and innovative solutions.

David Fitzhenry

Chief Executive Officer

Dave has been helping life sciences companies bring cutting edge medicines and medical devices to the market for more than two decades. Joining Trinity as Employee #3 as an Associate after college, Dave has led Trinity’s growth of 20% year over year, developing and implementing best practices for new product and launch planning, due diligence for licensing and acquisitions, as well as industry-leading forecasting methods — experience that led Consulting Magazine to name him a 2017 Global Leader in Consulting.

When Dave isn’t driving commercialization forward for life science companies, he is often driving his 3 boys to school and various sporting events. He’s also active in the Concussion Legacy Foundation, which advances the study, treatment and prevention of the effects of brain trauma in athletes and other at-risk groups, a cause he is passionate about. Dave earned an AB from Harvard University.

Leslie Sandberg Orne

Senior Partner & Chief Client Officer

Leslie oversees the delivery of integrated consulting, insights and analytic services to our customers. Since joining Trinity, she has been a critical advisor to hundreds of customers across thousands of projects, spanning an array of therapeutic areas and business models. Her support for billions of dollars in strategic transactions and the launches of dozens of products gives Leslie a unique vantage point on the industry, and her evidence-forward approach to strategic questions empowers customers to make smart, informed and timely decisions.

Leslie graduated summa cum laude and Phi Beta Kappa from Dartmouth College with a BS in Biology. While at Dartmouth, she was also an All-American and captain of the National Championship varsity sailing team. She spends her down time chasing around her two girls and spending as much time at the beach, ski slopes and horse barn as possible.  

John Corcoran


Since founding Trinity in 1996, John has cultivated the heavily quantitative, cross-functional approach to consulting that has remained at the core of the company throughout its expansion of service offerings and its international growth of team members and offices.

Trinity marks the fourth company John has founded or co-founded, after successful endeavors in social media, medical devices, and pharma- and biotech-focused software development.

He graduated magna cum laude from Harvard College before earning his M.A. from Northeastern and his M.C.R.P. from the John F. Kennedy School of Government at Harvard, and he devotes his free time to his family.

Gary McWalters

President, TGaS

Gary is a seasoned pharmaceutical industry professional with more than 20 years’ experience in marketing and sales. Previously, he led the day-to-day management and commercialization of all TGaS Advisor solutions and headed the Marketing Advisory Practice. Earlier in his career, Gary consulted with Abbott Laboratories as they built out a Respiratory Marketing group and spent four years at Kos Pharmaceuticals where he served in a number of marketing positions, including Group Director, Respiratory and Hypertension brands. He started his pharmaceutical career at Schering-Plough, where he held a variety of sales, marketing and management positions.

Gary holds a BA in Advertising from the School of Communications at Temple University. In his free time, Gary enjoys traveling with his family, and is an avid golfer.

Neal Dunn

Senior Partner, Head of Insights and Analytics

Neal Dunn

Senior Partner, Head of Insights and Analytics

Neal is a member of the Executive Committee helping to set and deliver on Trinity’s core strategic imperatives. As Head of Insights & Analytics, Neal and his team provide Trinity’s clients with strategically sound and tactically actionable results to critical brand questions through a breadth of marketing research, real world evidence and commercial analytic methodologies. Previously, Neal led Trinity’s Primary Market Research group for 10 years building a nascent business into a core practice area. Prior to joining Trinity, Neal worked for a boutique market research firm where he helped build strong client relations and internal operations as a member of its executive team. He began his career at Bristol-Myers Squibb in brand management and marketing research for in-line and pre-launch products.

Neal earned a B.S. in Neurobiology and Behavior at Cornell University. Outside of the office, Neal is devoted to living a fit active life with his family, enjoying triathlon, skiing, paddling and photography.

Herman Sanchez

Senior Partner

Herman has been working in the life sciences industry for over 20 years in various positions including designing and running randomized trial research, optimizing of clinical administration of health services, and working as a strategic consultant to the life sciences industry. He joined Trinity over a decade ago and has worked closely with clients to support strategic decision making across the product lifecycle. As a leader at Trinity, he has worked to build out of Trinity’s European office and helps to run and build our centers of excellence in Market Access, Launch, and Health Economics and Outcomes Research (HEOR).

At home, when he isn’t reading, he enjoys jumping on the trampoline with his two kids and wife and cooking various types of meals. He is a proud supporter of Peace First, which empowers young people to change the world around them, where in college he served as one of the organization’s leaders and has been an active contributor and consultant since (https://www.peacefirst.org/). Herman earned an MBA from the Tuck School of Business at Dartmouth and an AB from Harvard University, where he played rugby and sang in the gospel choir (Kuumba).

Mark Beucler

Senior Vice President & CFO

Mark is responsible for Trinity’s financial and administrative functions including accounting, finance, treasury, human resources, corporate IT and facilities. With a career spanning more than 25 years, Mark brings diverse experience in financial and general management, business leadership and corporate strategy. Before joining Trinity, Mark served as senior vice president and CFO for Eliza Corporation, a Healthcare Technology services company. Prior to that, he has held CFO and General Management positions in public and private equity owned life sciences businesses.

Mark earned a Bachelor of Science in accounting and management from Northeastern University and became a CPA while working for Deloitte.

Kirsten Brady

Senior Vice President, Commercial

Kirsten joined Trinity as our SVP, Commercial. Kirsten began her career in sales and marketing at Merck, AstraMerck and Pfizer, helping to launch several leading blockbuster drugs. She then joined the Brand Management practice at Campbell Alliance/inVentiv Health leading new product planning, strategic business development and Launch Excellence projects for a range of customers from emerging biotech to large pharma companies. Most recently, Kirsten led Global Marketing Business Development at inVentiv Health, and served as a Managing Director for FCB Health.

Kirsten earned an MBA from the University of Michigan, and a BA from Dartmouth College in English and French. Kirsten is a hot yoga enthusiast and aspiring painter. She and her husband renovate historic homes, when not busy with their 3 children and French bulldog.

John C. Gillis

Senior Vice President, Head of Commercial Data Solutions

John has been providing commercial data strategy and innovative data management and business intelligence solutions to life sciences companies for nearly two decades. A founding member of a former Trinity subsidiary, Shyft Analytics, John has been involved in a breadth of projects over the years, leveraging complex data sets, analytics and technology to deliver the best solution for our clients.

John attended Boston University for Computer Science. When John isn’t focused on the continued growth of Trinity’s Commercial Data Solutions, he can be found spending time with his family.

Tim Wohlgemut

Senior Vice President, New Products & Strategies

Tim is a veteran of the healthcare and technology space – contributing to many new solutions for customers along the way.  He joined Trinity with the acquisition of TGaS Advisors, where he led product innovation and strategy for 4 years. Previously, he was Co-President of Millennium Research Group (now part of DRG) and founded an advisory firm focused on the energy and healthcare industries. He also gets excited by renovating century homes.

Tim is a graduate of the University of Waterloo where he majored in psychology and played volleyball. Outside of work, Tim is involved as a board member and volunteer with several local organizations focused on immigration and community building.

Alexander Chiang


Alex has supported biopharmaceutical companies with commercialization challenges for over ten years. A trusted adviser of his clients known for his ability to bring clear, actionable solutions to complex questions, Alex has years of experience bringing the right mix of evidence to advise clients with issues ranging from New Product Planning, pre-launch Commercialization, and Business Development strategy. Now the head of Trinity’s New York City Office and one of the leaders of the firm’s oncology practice, Alex started at Trinity out of college as an associate.

Alex holds a BA from Princeton University and an MBA from Columbia University. When not in the office, Alex can be found exploring the nooks and crannies of his adopted home of Brooklyn with his wife, daughter, and dog.

Aparna Deshpande

Partner, Head of Market Research

Aparna leads the design and execution of primary market research projects in support of Trinity’s consulting engagements. She specializes in shaping therapeutic area commercial strategy through insights and analytics across multiple disease areas. Aparna’s focus is on helping clients identify the “right” business questions, developing a hypothesis-based approach to address the question and leveraging her analytical capabilities to identify the most efficient approaches to testing the hypotheses.

With over a dozen years of domestic and international experience in pharmaceutical market research, Aparna holds a PhD with a concentration in Pharmaceutical Market Research from the University of Georgia and is a trained pharmacist. Winning praise for her health care policy research, she has been an invited speaker to the Federal Drug Administration (FDA), and her quantitative research has been widely published in public policy, health communication, pharmacy education and pharmacoeconomic journals.

Outside the office, Aparna enjoys staying active with her husband and sons, particularly kickboxing and crossfit training.

Lauren Quinn Grant


Lauren has been working for over 15 years in life sciences consulting, helping biotech and pharma companies bring solutions to strategic issues across the product lifecycle.  Joining Trinity in 2005, Lauren is most valued for the strategic insights she brings and the long term partnerships she has developed with countless clients and companies.   While her expertise spans across many project types, Lauren is most known for her work in New Products Planning and due diligence support.  Lauren spearheaded the creation of Trinity’s menu of BD support offerings, including Trinity’s proprietary QuickQuant.

Lauren earned a BA from Princeton University, where she played field hockey. She also earned an MBA from the Carroll School of Management at Boston College. Outside of Trinity, Lauren can be found chasing after her three young children and getting her competitive spirit out in an adult field hockey league.

Nandini Hadker

Partner, Head of Health Economics & Outcomes Research

Nandini has over 20 years of experience identifying and actualizing success drivers in the marketplace for life science customers. She specializes in assessing market opportunities, developing arguments to “make the use case” for payers, healthcare professionals, patients and consumer groups, and building compelling scientific evidence. Leveraging best-in-class approaches in qualitative/quantitative research, claims, real-world evidence, health economics modeling, and strategy, Nandini’s focus is helping customers get appropriate share and access, with pricing commensurate to product value. Prior to Trinity, Nandini led the Commercialization Strategy Group for United BioSource Corporation /Evidera. The lead feature in Boston Herald’s “Women Leaders under 40” in 2010, Nandini is published extensively in peer-reviewed publications and has discussed drug pricing at the Yale Healthcare Conference.

Nandini has a BA from the University of Connecticut and MA in Economics from Boston University.  When not at Trinity, Nandini can be found attending myriad sporting and school events with her kids, or at home, cooking, gardening and socializing with neighbors.

Fotios Kokkotos

Partner, Head of Statistics

Fotios is an accredited professional statistician and data scientist with over 25 years of experience in statistical consulting. With expertise in predictive modeling, machine learning, statistical modeling, data analysis, Fotios created Trinity’s statistics and advanced analytics groups. He also introduced Trinity to health economics and outcomes research projects and identifies appropriate databases to support customer project needs. Prior to joining Trinity, Fotios served as manager with PricewaterhouseCoopers.

A board member of American Statistical Association’s accreditation committee, which reviews and approves professional statisticians around the world, Fotios earned a doctorate degree in mathematical statistics from American University. When not immersed in data science or academic collaborations, Fotios enjoys traveling with his family and watching a soccer game or two.

Stephen Fleming


Steve draws on 15 years of experience in the global life science industry to provide leaders and companies with innovative commercial strategy support. As a partner, his leadership has helped grow Trinity into one of the top life science consultancies with an enhanced focus on people development and culture. Steve focuses on commercialization strategy including new product planning, licensing and acquisition support, launch excellence and in-line operational support.  An industry leader in key commercialization areas such as forecasting, Steve has presented on best practices and innovation in the space. Steve holds an undergraduate degree from Princeton University and an MBA from the Carroll School of Management at Boston College. When not at Trinity, Steve can be found spending time with his family including 3 children.

Eric Sholk


Eric has been working with the life sciences industry to address a range of strategic needs for nearly two decades. With expertise in new product planning, business development, and launch planning/strategy, he helps companies to identify, evaluate, and execute on new global growth opportunities at the corporate, franchise, and product levels. Prior to joining Trinity, Eric worked with Boston Biomedical Consultants, a leading provider of consulting services to the In Vitro Diagnostics Industry.

Eric received a BA in neuroscience with honors from Middlebury College and his MBA from the Tuck School of Business. Outside of work, Eric can be found spending time with his family, including coaching his three sons in a variety of sports.

Yogesh Soneji


Yogi has over 15 years of experience in the life sciences industry and advises clients on a wide range of strategic decisions. He has overseen hundreds of engagements supporting established as well as emerging life sciences companies over his career. Yogi brings expertise in new product planning, corporate and franchise strategy, and business development support. His engagements span the healthcare spectrum, including projects on drugs, devices, diagnostics and digital solutions. Yogi also advises private equity firms, venture capital funds, and other financial services firms on strategies and potential investments in the healthcare sector. At Trinity, he has supported the expansion of the advisory business, which has grown ten-fold since he joined the firm in 2005. Internally at Trinity, Yogi has spearheaded several growth efforts, including the firm’s global expansion (to Europe and India), innovation and product development, and strategic M&A.

Outside of work, Yogi enjoys traveling to spend time with friends and extended family who are spread across several continents. He is a fan of Pearl Jam, cricket, and Chef Jacques Pepin, and has a newfound love of cooking. He currently lives with his wife and son in Washington, DC.

Yogesh earned his Masters of Engineering Management from Dartmouth College and a BE from the University of Mumbai.

Vivian DeWoskin

Director, Commercial

Vivian has experience designing, managing, and executing projects across the full breadth of Trinity’s offerings. Having worked in a variety of therapeutic areas in her career, she primarily focuses in oncology and orphan diseases. Vivian specializes in supporting emerging biotech clients in preparing for their first commercial product launch through strategic launch planning, research and analytics, thoughtful approaches to organizational growth, and a bit of creativity. Having worked at multiple different Trinity office locations over 8 years, she is now based out of San Francisco.

Vivian has a BA from Princeton University in Psychology and Neuroscience, and an MBA from Berkeley Haas. When she isn’t working, Vivian can be found hiking and camping in the hills around Oakland with her family and her 4-year old rescue husky.

Michele Andrews


Michele has led Trinity initiatives in strategic planning, product launch, payer, global, and commercial assessments for both established and emerging life sciences companies. With therapeutic area expertise that is broad and deep, Michele has completed over 15 years of engagements and launches in oncology, metabolics, cardiovascular, central nervous system, and a range of specialty, orphan, and traditional markets. Having started her life sciences career in industry in marketing and brand roles at AstraZeneca and Genentech, she moved to strategy and leadership roles at AmeriSource Bergen Specialty Group and Ogilvy CommonHealth Worldwide.

Michele holds a BS in biology and mathematical sciences from Montclair State University and a Masters of Public Health from Columbia University. In her spare time, she does her best to keep up with her son in high school and uses exercise as a way to process the day.

Kevin Chithran


Kevin partners with customers to implement creative, data-supported solutions. His breadth of work spans all commercial activities, such as portfolio design, new product planning, forecasting (including supporting research and analytics), launch planning & tracking, opportunity assessments, and patient services. With a deep understanding of major therapeutic areas, with specific focus on oncology, immunology, neurology, pain, and other specialty markets, he co-leads Trinity’s NYC office and helps drive the company’s forecasting innovation engine.

Kevin earned a BA from Dartmouth College and a Masters of Public Health from Tufts University. When he isn’t in the office, Kevin can be found playing basketball and tennis, or traveling with his wife, camera in hand.  

Chad Alan Faulkner


Chad brings deep expertise to integrated research solutions, bridging elements of research, analytics, and strategy to inform some of our clients most complex and challenging issues. Chad’s specialty lies at the nexus of corporate strategy and asset diligence, helping customers to decide how to invest in both internal and external development opportunities, but also shape larger franchises and portfolios in an ever-evolving and competitive landscape. Chad’s work has touched billions of dollars of acquisitions over the years, both on the buy- and sell-side.

Chad earned an AB in Molecular Biology from Princeton University, where he also pole vaulted for the Track & Field team. Outside of Trinity, Chad enjoys trying a new cocktail, catching an old movie, and raising his young pup.

Amanda Francis


Amanda has been a key leader of Trinity’s strategic advisory group for a decade. Known for her expertise in new product planning, strategic business development and L&A work, Amanda also specializes in leading large, integrated projects that involve strategic advisory services, primary market research, and secondary data analytics. Over nearly a dozen years, she has developed deep expertise in central nervous system, psychiatry, and orphan disease markets.

Amanda earned a BA from Princeton University in Molecular Biology and Neuroscience. An avid runner, Amanda loves hiking on weekends with her husband, daughter, and their yellow lab.

Kevin Francis

Principal, Head of Real World Evidence

Kevin is a thought leader with extensive experience focusing on patient-level data. Since joining Trinity, Kevin has helped cultivate a center of excellence around data and analytics. Leading Trinity’s Real-World Evidence practice, Kevin and his team focus on driving insights to inform commercial strategy and planning as well as evidence generation for health economics outcomes research (HEOR) teams.

Kevin received a B.S. in Managerial Economics and International Business from Bentley University. During his free time, Kevin stays active with his family, running trails with his family’s lab, and finding projects around the house.

Christian Frois


Christian is a recognized and widely published expert on pricing, contracting, market access and payer evidence strategy. He leads Trinity’s pricing, market access, reimbursement and contracting (PARC) group, and has supported the development of PARC strategies for more than 50 assets in the US and ex-US. His experience includes developing US and global launch, marketing, pricing/contracting, market access, and evidence generation strategies for pharmaceutical and medical device products across multiple therapeutic areas and therapeutic settings. His work regularly puts him in touch with payers, health technology assessments (HTAs), and other critical stakeholders in the US, Europe and around the world. Christian brings direct industry experience, serving as the global pricing, market access, and health economics lead, sitting on global blood therapeutics (GBT) and GPT teams, for a major potential oncology blockbuster.

Christian has a Ph.D. in Economics from MIT and degrees from Ecole Polytechnique and Ecole Normale/EHESS in France. Christian loves that Greater Boston’s emergence as a biotechnology leader enables him to frequently bike from meeting to meeting, and spending more time with his two teenagers.

John Greenaway


John co-leads our San Francisco office and team and drives growth in our strategic advisory service offering in Pricing, Access, Reimbursement, and Contracting (PARC). Since 1999, John has been leading strategic contracting initiatives, brand planning, forecasting, and product launch strategies to inform customers’ data-driven strategic decision making with market research, quantitative analysis, and financial modeling. His therapeutic expertise includes oncology, neurology, hemophilia, and medical devices. John is also a published author, having led several Trinity perspective pieces, including “Innovative Contracting Solutions in a Changing Healthcare Landscape” and “Why So Slow? Demystifying The Barriers To U.S. Biosimilar Adoption.”

John holds an MBA from the Kellogg School of Management and a BS in electrical engineering from the University of Michigan. A former United States Air Force officer, John runs 75-100 miles most months and enjoys the Bay Area’s outdoor lifestyle where he struggles to keep up with his three young children and their interests and activities.  

Maria Gumina


Maria brings a decade of pharmaceutical market research experience to Trinity’s customers. With expertise in oncology, orphan diseases, benign hematologic conditions, and inflammation and immunology, Maria focuses on research engagements that span the patient journey, new product opportunity assessments, scenario planning, and promotional material testing.

Trained as a research scientist, Maria holds a PhD in Biology with a concentration in Immunology from Boston College. Outside of Trinity, Maria spends her time traveling and reading. She also enjoys giving back to her community as a volunteer teacher and mentor to middle school students through Citizen Schools.

Blair Miller


Blair specializes in assisting innovative biopharma companies to create value and make strategic decisions across the product lifecycle.  In particular, Blair focuses on assessing value for novel therapeutics, both as part of L&A diligence as well as for internal corporate strategy and pipeline prioritization purposes.  Since joining Trinity in 2011, he has developed deep expertise in neuromuscular, neurological, autoimmune, and rare metabolic disorders and specializes in working with novel therapeutics including gene therapies, nucleotide-based therapies, and CRISPR therapeutics.  Over the years, Blair has been deeply involved in bringing numerous rare disease products to successful launch.

Blair earned a BA from Princeton University in Molecular Biology and Finance. When he isn’t in the office, Blair can be found playing a variety of sports or traveling, hiking, and sightseeing with friends and family.

Krista Perry


Krista supports biopharma and biotech companies in their BD and commercialization strategy. Krista joined Trinity in 2006 and co-leads the SF office. Krista partners with companies focused on commercial assessments, BD/NPP strategy, pipeline/portfolio prioritization and strategy, and launch roadmap planning bringing deep experience in rare diseases. Clients leverage Krista’s insights in navigating early-mid clinical stage product development opportunities and the commercial needs required to recognize their full potential, including: analog analyses, forecasting, market research, L&A opportunities, and cross-functional strategy & alignment on.

Krista works remotely from Idaho enjoying the outdoors with her family and is active in multiple non-profits that work with youth. Krista earned her psychology and pre-med degree from Dartmouth College, captaining the women’s basketball team to 2 Ivy Championships.

Lauren Peters Radeck


Lauren has been in the life sciences industry for over a decade and specializes in helping clients answer some of their ‘fuzziest’ questions. She enjoys working as a thought partner with her clients, providing structure and actionable solutions around key strategic questions. Her expertise spans many therapeutic areas, including Women’s health, neurology, and immunology.  Lauren’s experience from preclinical biotechs to big pharma allows her to bring perspective tailor-made for the question at hand. She specializes in integrated projects – creating a holistic ‘so-what’ story from multiple information sources.

Lauren started her career in direct-to-consumer advertising at McCann Erickson, primarily focused on GSK’s launch of their HPV vaccine, Cervarix. Lauren holds an MBA from Tuck School of Business at Dartmouth and graduated magna cum laude from Washington and Lee University with a BS in Business Management and English. She spends her time trying to keep up with her two young children and waiting for SEC football season.

Jillian Godfrey Scaife


Jillian has nearly 15 years of experience as a life sciences strategy consultant leading multi-disciplined teams to answer key strategic business questions for some of the world’s top pharma and biotech companies as well as emerging firms. One of the earliest members of the Trinity team, joining when there were only about 25 employees, Jillian has played a central role helping the company expand its offerings in commercial analytics, launch planning, health economics and outcomes research, and pricing/market access.

A graduate of Princeton University, where she received her degree in Molecular Biology, Jillian also earned an MPH from Johns Hopkins Bloomberg School of Public Health and an MBA from the FW Olin Graduate School of Business at Babson College. Outside of the office Jillian can be found enjoying a leisurely run or playing with her two young children.

Susheel Sukhtankar

Principal, Head of Commercial Analytics

Susheel heads Trinity’s Commercial Analytics group and provides operational support across demand forecasting, field operations, and ad hoc analytics to our partners in the life sciences industry. Susheel started his consulting career in pharmaceutical data management and reporting before going on to lead engagements leveraging primary research and secondary data with a focus on commercial operations and analytics. With in-depth knowledge of the pharmaceutical, biotech, and medical device industries, Susheel has worked in multiple therapeutic areas including diabetes, oncology, infectious diseases, central nervous system, and gastrointestinal disorders.

He holds a bachelor’s degree in Biomedical Engineering from the University of Mumbai and a master’s degree in Bioinformatics from Georgia Tech. Susheel enjoys family time with his wife and two children as well as swimming, music, and soccer.

Steven Yonish


Steve has broad life sciences consulting experience spanning over 20 years with emphasis on integrating commercial strategy with advanced analytics. Throughout his career, from Bristol-Meyers Squibb to consulting engagements, Steve has applied diverse research methods–including qualitative interviews, quantitative surveys and sophisticated modeling–to strategic issues in commercial development across a range of therapeutic categories and stakeholders. Since joining Trinity, Steve has been a strategic partner for many clients, leading a broad array of global engagements to inform commercialization decision points including patient journey, demand assessment, market mapping, segmentation, positioning, and promotional material development.

Steve has a Ph.D. in Political Science from the University of Wisconsin-Madison and an Economics degree from Cornell University.  Outside of Trinity, Steve can be found driving his 3 boys to all regions of New Jersey for baseball and basketball games, or rowing on Lake Carnegie when everyone else is sleeping.

Michelle Adams

Senior Director, Organizational Development

Michelle has a deep passion for empowering leaders and energizing culture to accelerate growth for 15 years. Formerly at Wayfair.com and athenahealth, Michelle joined Trinity to build up a Talent Management function that supports the integration of new hires and leaders, organizational design and succession planning, career pathing and performance management, and engagement strategies.

Michelle also has expertise in capacity planning and resource management, leader and manager coaching and planning corporate meetings & communications, and leads Trinity’s Corporate Social Responsibility and Diversity & Inclusion platforms.

A California native, Michelle has a degree in Sociology from the University of California, Santa Barbara. Outside of work, Michelle can be found playing pub trivia or taking urban hikes to soak up the beauty and history of the Boston area.

Jessie Cawley

Senior Director, Human Resources

Jessie leads all of Trinity’s core human resources functions, including recruiting. With over 15 years of experience in the human resources field, she understands the critical role people play in Trinity’s growth and the success of life sciences customers around the world. Jessie worked at SVB Leerink (formerly Leerink Swann) prior to joining Trinity.

She received her MS in Human Resource Management from Emmanuel College and earned her BS in Business Administration from the University of Vermont. Jessie enjoys spending time with her two little daughters and traveling.

Melissa Rosenbaum

Senior Director, Finance

Melissa leads a high-performing team, implementing scalable Customer Relationship Management (CRM) and Enterprise Resource Planning (ERP) systems, integrating acquisitions and strengthening the timing and accuracy of financial reporting. Melissa began her career in public accounting where she sharpened her technical accounting skills and gained her CPA license before transitioning into roles where she provides value within private equity-backed companies leading accounting organizations.

A self-starter who learned independence early, Melissa supported herself financially through college and graduated from UMass Boston with her bachelor’s degree in accounting. When she’s not focused on very structured accounting work, Melissa enjoys using the other side of her brain to create — cooking and gardening — and raising her two little girls, fostering their interests and helping them learn about the world.

Jeff Zahr

Executive Director, General Administration

Jeff Zahr

Executive Director, General Administration

Jeff has been focused on operational efficiency for over two decades. With expertise in recognizing business challenges and fashioning technological or process-oriented solutions that drive the business forward, Jeff oversees Trinity’s Information Technology, Compliance, Facilities, Knowledge Management and general administration. Despite his diverse industry experience, Jeff has had pharmaceutical and biotech roots since early in his career.

Jeff earned a BA in Economics at the University of Massachusetts in Amherst, Mass. In Jeff’s free time he is often traveling with his family and participating in road races, century rides and triathlons all over the world.

Alexander Fink

Managing Partner, EU Office

Alexander leads Trinity’s operations in Europe. He brings over two decades of experience as a Management Consultant in the life sciences industry. Alexander advices life sciences executives and investors on complex issues that require strong content expertise and analytical rigor paired with creativity and a deep understanding of the industry success logic. He supports his clients mainly in franchise strategy, launch planning, go-to-market strategy, product positioning, lifecycle management, corporate growth strategy and commercial excellence.

Alexander very much enjoys working in teams and is passionate about developing people.

Alexander lives in Munich and works globally with his clients, after having spent extended periods of time in New York, Johannesburg and Jakarta. He has already advised more than 70 clients in far over 300 strategic assignments covering all continents and more than 40 countries.

Outside of work, Alexander enjoys traveling and spending time with his wife, daughter and son. He is a true foodie and passionate cook.

Alexander has studied business administration in Germany, UK and USA.

Jackson Carroll

Principal, EU Office

Jackson has advised biopharmaceutical companies on their commercialization challenges for over 15 years. Clients look to Jackson to bring actionable strategic advice supported by strong analytical evidence to address their commercialization concerns. Jackson has advised clients in Europe, the US and other countries on issues ranging from Corporate and Portfolio strategy, Business Development strategy, assessment of key opportunities, Go-To-Market strategy and Launch planning. Currently a Principal in Trinity’s Munich Office, Jackson brings experience both from other consulting firms and working directly with clients as an independent advisor.

Jackson holds an MBA with Distinction from London Business School. When not in the office, Jackson likes to challenge himself with some open water swimming and did once manage to swim the English Channel.